|
CAS No:352458-37-8
Delafloxcain meglumine 352458-37-8 pharmaceutical intermediates
|
|
CAS No:881681-00-1
Vonoprazan 881681-00-1 pharmaceutical intermediates
|
|
CAS No:881677-11-8
5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde 881677-11-8 pharmaceutical intermediates
|
|
CAS No:1260141-27-2
Vonoprazan fumarate 1260141-27-2 pharmaceutical intermediates
|
|
CAS No:1744-22-5
Riluzole 1744-22-5 pharmaceutical intermediates
|
|
CAS No:121808-62-6
Pidotimod 121808-62-6 pharmaceutical intermediates
|
|
CAS No:120202-66-6
Clopidogrel sulfate 120202-66-6 pharmaceutical intermediates
|
|
CAS No:186826-86-8
Moxifloxacin hydrochloride 186826-86-8 pharmaceutical intermediates
|
|
CAS No:915087-33-1
Enzalutamide 915087-33-1 pharmaceutical intermediates
|
|
CAS No:1392275-56-7
Tenofovir Alafenamide Fumarate 1392275-56-7 pharmaceutical intermediates
|
|
CAS No:202138-50-9
Tenofovir disoproxil fumarate 202138-50-9 pharmaceutical intermediates
|
|
CAS No:154361-50-9
Capecitabine 154361-50-9 pharmaceutical intermediates
|
|
CAS No:183319-69-9
Erlotinib hydrochloride 183319-69-9 pharmaceutical intermediates
|
|
CAS No:27143-07-3
Acetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester 27143-07-3 pharmaceutical intermediates
|
|
CAS No:545445-44-1
3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one 545445-44-1 pharmaceutical intermediates
|
|
CAS No:1267610-26-3
1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone 1267610-26-3 pharmaceutical intermediates
|
|
CAS No:503615-03-0
3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one 503615-03-0 pharmaceutical intermediates
|
|
CAS No:5117-12-4
4-Acryloylmorpholine 5117-12-4 Acrylates
|
|
CAS No:3775-90-4
2-(tert-Butylamino)ethyl methacrylate 3775-90-4 Acrylates
|
|
CAS No:105-16-8
Diethylaminoethyl methacrylate 105-16-8 Acrylates
|
